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Purpose: To describe an unusual case of intravenous drug abuse associated endogenous endophthalmitis
presenting with an iris abscess.
Observations: A 30-year old female with history of intravenous drug use presented with a two-week
history of redness and blurry vision in the right eye. An initial diagnosis of anterior uveitis was made.
However, she worsened on topical steroids and mydriatics. She was found to have a hypopyon and an iris
abscess. She received broad spectrum antibiotic and antifungal treatment with voriconazole, this lead to
signiﬁcant clinical improvement. She was discharged on oral ﬂuconazole and lost to follow up. The
patient was noncompliant with the antifungal treatment. The hypopyon and iris abscess recurred, and
she required a vitrectomy with iridectomy, along with intravitreal and systemic antifungal treatment.
The vitreous cultures and surgical specimen of iris issue were positive for Candida albicans, and she
received voriconazole. This led to resolution of the condition with a ﬁnal visual acuity of 20/20 at six
month follow up.
Conclusions and importance: An iris abscess is a rare clinical presentation of intravenous drug use-
associated endogenous endophthalmitis and as a result may present a diagnostic challenge as it re-
quires a high level of clinical suspicion and a detailed social history to elicit the drug abuse. Early
diagnosis and aggressive therapy is the key to better visual outcomes in these patients.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Endophthalmitis is a rare but severe intraocular infection with
the risk of poor visual outcome. Endogenous endophthalmitis
comprises just 2e8% of all cases of endophthalmitis.1,2 This condi-
tion most often arises secondary to systemic infection, although
few cases have recently been reported in immunocompetent in-
dividuals as well.3e5 Intravenous drug use (IVDU) has remained a
major public health concern in urban settings for many decades.6e8
Recently, a large review by Jackson et al. found IVDU to be the
second most common predisposing factor for development of
endogenous endophthalmitis.9 Here, we highlight a rare case of
intravenous drug abuse associated endogenous endophthalmitis
presenting as an iris abscess in an otherwise healthy young female
patient.
1.1. Case report
A 30-year-old Caucasian female with no previous ocular history
presented to a general ophthalmologist with gradually increasing
redness and blurry vision in her right eye for 2e3 weeks accom-
panied by progressively worsening throbbing eye pain and occa-
sional headaches. On initial exam, visual acuity was 20/70 OD, 20/
20 OS. Intraocular pressure in the right eye was 10 mmHg. The
conjunctiva of the right eyewas injected. On slit-lamp exam, cornea
keratic precipitates were present and 3 þ cells were noted in the
anterior chamber. The view of the iris was hazy, but the lens was
clear. Anterior vitreous cells were also present. The examination of
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the left eye was within normal limits. A diagnosis of anterior uveitis
was made and the patient was started on 1% prednisolone forte
every 1e2 hours and cyclopentolate 1% three times a day.
The patient returned three days later with signiﬁcantly wors-
ening pain and was urgently referred to a retina specialist for
evaluation. She was found to have a visual acuity of 20/200 OD and
an intraocular pressure of 6 mmHg. At this time, the cornea was
edematous with numerous keratic precipitates, and a 1.5 mm
hypopyon was detected. Detailed and persistent review of systems
revealed that she had an axillary abscess one year prior. She was
homeless and had a history of Hepatitis C seropositivity. She
endorsed IVDU, with her last use being a few months ago, thus
elevating the concern for a possible infectious etiology. Anterior
chamber and vitreous tap were performed with intravitreal in-
jections of ceftazidime (2.25mg/0.1ml), vancomycin (1mg/0.1ml),
and voriconazole (100mg/0.1ml). She was admitted to the hospital,
started on IV vancomycin, cefepime, and voriconazole, and blood
cultures were obtained. All cultures from this admission were
negative for both bacteria and fungal species.
Over the next 48 hours, while still hospitalized, she improved
symptomatically. Her hypopyon resolved, and her visual acuity
returned to 20/30 OD by day 4. Only trace cells remained in the
anterior chamber and vitreous on examination of the right eye. All
cultures remained negative. Prior to discharge, she was switched to
ﬂuconazole due to patient's lack of insurance coverage and con-
cerns for compliance issues. Given her apparent response to the
treatment while she was an inpatient, she was discharged on oral
ﬂuconazole.
The patient was lost to follow up and returned two weeks later
with blurry vision and brow ache. She informed us that she was
noncompliant with her oral ﬂuconazole. On examination, her visual
acuity was 20/50 OD. There was recurrence of the hypopyon along
with a nodular elevation in the iris with ﬁbrin in the anterior
chamber, as well as anterior capsular and subcapsular lens opacities
(Fig. 1). Posterior segment exam remained unremarkable. She was
readmitted and restarted on systemic voriconazole, cefepime, and
vancomycin. She underwent a diagnostic and therapeutic pars
plana vitrectomy with lensectomy and iridectomy. Vitreous cul-
tures were positive for Candida albicans, sensitive to both ﬂucon-
azole and voriconazole. A ﬁnal diagnosis of chronic granulomatous
inﬂammation involving the iris stroma and surface with fungus
present was established by histopathology (budding yeast) (Figs. 2
and 3). She was discharged on oral voriconazle for 4 weeks, with
prednisolone forte and atropine drops. Her vision returned to 20/20
with a þ12D contact lens on six month follow up (Fig 4).
2. Discussion
Endogenous endophthalmitis is a rare intraocular infectionwith
potentially poor visual prognosis that is responsible for a relatively
small fraction of all cases of endophthalmitis. These infections can
arise from both bacterial and fungal organisms, most commonly
Staphylococcus, Klebsiella, Aspergillus or Candida albicans.5 Intrave-
nous drug abuse is now being recognized as an emerging cause of
endogenous endophthalmitis in larger cities and tertiary centers.
This disease is often misdiagnosed in this population as it is
particularly difﬁcult to identify for a number of reasons. These
Fig. 1. Slit lamp photograph of patient's right eye at follow up visit showing a hypo-
pyonwith ﬁbrin in the anterior chamber, a yellowish superonasal elevation and a mass
at the pupillary border.
Fig. 2. Iris stroma with chronic granulomatous inﬂammation composed of histiocytes
and giant cells.
Fig. 3. Fungal spore with budding yeast (arrowhead) consistent with Candida species.
Fig. 4. Slit lamp photograph of patient's right eye at six month follow up.
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patients are typically young and otherwise healthy. Many of these
patients are not forthright about their history of illicit drug use and
may have poor compliance with follow up appointments. Addi-
tionally, there is potential for latency between inoculation of the
pathogen from IVDU and the clinical presentation of signs and
symptoms.10 Therefore, a high level of suspicion and the ability to
get the history of drug abuse is very important for diagnosis.
Given the relative rarity of this condition, the speciﬁc treatment
guidelines for endogenous endophthalmitis are varied given the
relative paucity of large case series. The typical clinical presentation
of this disease is chorioretinitis with symptoms including
decreased vision, eye pain, eye redness, photophobia, ﬂoaters, and
eyelid swelling.5 Clinical signs such as hypopyon, subconjuctival
hemorrhage, conjuctival injection, iritis/retinitis, corneal edema,
anterior chamber cells, and reduced or absent red reﬂex may also
be present. An iris abscess is rare, making this particular case a
diagnostic challenge. Only a few cases have been reported in the
literature, notably one secondary to endocarditis caused by Staph-
ylococcus aureus,3 and one after a routine dental cleaning caused by
Strep intermedius.11 To our knowledge, only one other case of an iris
abscess associated with IVDU has been reported.4 However, the
suspected history of IVDU was never conﬁrmed by the patient in
this case.
In addition to highlighting a unique clinical presentation of this
condition, this case may also serve as an example of how the choice
of antifungal therapy may affect clinical outcome. When this pa-
tient initially presented, she was placed on voriconazole and her
condition improved signiﬁcantly as an inpatient. However, due to
ﬁnancial circumstances, at time of discharge she was switched to
ﬂuconazole e a less expensive alternative to newer generation
triazole agents with less favorable ocular penetrance.12 The recur-
rence of disease and worsening of abscess most likely happened
due to noncompliance with the use of antifungal and possibly use
of ﬂuconazole which has lesser intraocular penetration. One could
argue that if she had been discharged on voriconazole initially and
been compliant with treatment, perhaps the reoccurrence and
surgical intervention could have been avoided.
3. Conclusions
The growing number of cases of intravenous drug abuse asso-
ciated endogenous endophthalmitis represents a change in the
demographics of patients with this disease. The atypical presen-
tation in this population contributes to the degree of difﬁculty of
correctly diagnosing this disease in these patients. A high level of
suspicion and the ability to get the history of drug abuse is
important for diagnosis. Early diagnosis and aggressive therapy is
the key to better visual outcomes in these patients. The common
presentation of endogenous endophthalmitis is chorioretinitis; an
iris abscess is rare, making this particular case a true diagnostic
challenge.
4. Patient consent
The patient provided oral consent for the publication of this
case.
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